Family history predicts major adverse cardiovascular events (MACE) in young adults with psoriasis

Journal of the American Academy of Dermatology

Volumn 75, Issue 2, 2016, Pages 340-346

  Egeberg, Alexander ^a   Bruun, Louise E ^a   Mallbris, Lotus ^b   Gislason, Gunnar H ^a,c,d   Skov, Lone ^a   Wu, Jashin J ^e   Hansen, Peter R ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b KAROLINSKA INSTITUTE   (Sweden)

^c The Danish National Foundation Research Center for Heart Arrhythmia   (Denmark)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^e KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

cardiovascular disease; epidemiology; family history; inflammation; psoriasis

Indexed keywords

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; YOUNG ADULT; CARDIOVASCULAR DISEASES; COMORBIDITY; DENMARK; GENETICS; POISSON DISTRIBUTION; REGISTER; RISK FACTOR; SOCIAL CLASS;

ADULT; CARDIOVASCULAR DISEASES; COMORBIDITY; DENMARK; FEMALE; HUMANS; INCIDENCE; MALE; POISSON DISTRIBUTION; PSORIASIS; REGISTRIES; RISK FACTORS; SOCIAL CLASS;

EID: 84973514616     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2016.02.1227     Document Type: Article

References (34)

1. 1 Parisi, R., Symmons, D.P., Griffiths, C.E., Ashcroft, D.M., Identification and Management of Psoriasis and Associated ComorbidiTy (IMPACT) project team. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol 133 (2013), 377–385.
2. 2 Armstrong, A.W., Schupp, C., Bebo, B., Psoriasis comorbidities: results from the National Psoriasis Foundation surveys 2003 to 2011. Dermatology 225 (2012), 121–126.
3. 3 Yang, Y.W., Keller, J.J., Lin, H.C., Medical comorbidity associated with psoriasis in adults: a population-based study. Br J Dermatol 165 (2011), 1037–1043.
4. 4 Gelfand, J.M., Neimann, A.L., Shin, D.B., Wang, X., Margolis, D.J., Troxel, A.B., Risk of myocardial infarction in patients with psoriasis. JAMA 296 (2006), 1735–1741.
5. 5 Armstrong, E.J., Harskamp, C.T., Armstrong, A.W., Psoriasis and major adverse cardiovascular events: a systematic review and meta-analysis of observational studies. J Am Heart Assoc, 2, 2013, e000062.
6. 6 Miller, I.M., Ellervik, C., Yazdanyar, S., Jemec, G.B., Meta-analysis of psoriasis, cardiovascular disease, and associated risk factors. J Am Acad Dermatol 69 (2013), 1014–1024.
7. 7 Horreau, C., Pouplard, C., Brenaut, E., et al. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol 27:Suppl 3 (2013), 12–29.
8. 8 Nielsen, M., Andersson, C., Gerds, T.A., et al. Familial clustering of myocardial infarction in first-degree relatives: a nationwide study. Eur Heart J 34 (2013), 1198–1203.
9. 9 Gisondi, P., Dalle Vedove, C., Girolomoni, G., Patients with psoriasis have a higher prevalence of parental cardiovascular disease. Dermatology 222 (2011), 330–335.
10. 10 Andersen, T.F., Madsen, M., Jorgensen, J., Mellemkjoer, L., Olsen, J.H., The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull 46 (1999), 263–268.
11. 11 Helweg-Larsen, K., The Danish Register of Causes of Death. Scand J Public Health 39 (2011), 26–29.
12. 12 Gaist, D., Sorensen, H.T., Hallas, J., The Danish prescription registries. Dan Med Bull 44 (1997), 445–448.
13. 13 Hvidtfeldt, U.A., Gerster, M., Knudsen, L.B., Keiding, N., Are low Danish fertility rates explained by changes in timing of births?. Scand J Public Health 38 (2010), 426–433.
14. 14 Egeberg, A., Mallbris, L., Gislason, G.H., Skov, L., Hansen, P.R., Risk of multiple sclerosis in patients with psoriasis: a Danish nationwide cohort study. J Invest Dermatol 136:1 (2016), 93–98.
15. 15 Madsen, M., Davidsen, M., Rasmussen, S., Abildstrom, S.Z., Osler, M., The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol 56 (2003), 124–130.
16. 16 Krarup, L.H., Boysen, G., Janjua, H., Prescott, E., Truelsen, T., Validity of stroke diagnoses in a national register of patients. Neuroepidemiology 28 (2007), 150–154.
17. 17 Olesen, J.B., Lip, G.Y., Hansen, M.L., et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study. BMJ, 342, 2011, d124.
18. 18 von Elm, E., Altman, D.G., Egger, M., et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370 (2007), 1453–1457.
19. 19 Parisi, R., Rutter, M.K., Lunt, M., et al. Psoriasis and the risk of major cardiovascular events: cohort study using the clinical practice research datalink. J Invest Dermatol 135 (2015), 2189–2197.
20. 20 Ogdie, A., Troxel, A.B., Mehta, N.N., Gelfand, J.M., Psoriasis and cardiovascular risk: strength in numbers part 3. J Invest Dermatol 135 (2015), 2148–2150.
21. 21 McBride, K.L., Garg, V., Impact of Mendelian inheritance in cardiovascular disease. Ann N Y Acad Sci 1214 (2010), 122–137.
22. 22 Charchar, F.J., Bloomer, L.D., Barnes, T.A., et al. Inheritance of coronary artery disease in men: an analysis of the role of the Y chromosome. Lancet 379 (2012), 915–922.
23. 23 Gudjonsson, J.E., Karason, A., Antonsdottir, A.A., et al. HLA-Cw6-positive and HLA-Cw6-negative patients with psoriasis vulgaris have distinct clinical features. J Invest Dermatol 118 (2002), 362–365.
24. 24 Rankinen, T., Sarzynski, M.A., Ghosh, S., Bouchard, C., Are there genetic paths common to obesity, cardiovascular disease outcomes, and cardiovascular risk factors?. Circ Res 116 (2015), 909–922.
25. 25 Suarez-Farinas, M., Li, K., Fuentes-Duculan, J., Hayden, K., Brodmerkel, C., Krueger, J.G., Expanding the psoriasis disease profile: interrogation of the skin and serum of patients with moderate-to-severe psoriasis. J Invest Dermatol 132 (2012), 2552–2564.
26. 26 Lu, Y., Chen, H., Nikamo, P., et al. Association of cardiovascular and metabolic disease genes with psoriasis. J Invest Dermatol 133 (2013), 836–839.
27. 27 Task Force for the Management of Dyslipidemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS), Catapano, A.L., Reiner, Z., De Backer, G., et al. ESC/EAS guidelines for the management of dyslipidemias: the Task Force for the Management of Dyslipidemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 217:Suppl (2011), S1–S44.
28. 28 Tam, L.S., Shang, Q., Li, E.K., et al. Subclinical carotid atherosclerosis in patients with psoriatic arthritis. Arthritis Rheum 59 (2008), 1322–1331.
29. 29 Eder, L., Zisman, D., Barzilai, M., et al. Subclinical atherosclerosis in psoriatic arthritis: a case-control study. J Rheumatol 35 (2008), 877–882.
30. 30 Evensen, K., Slevolden, E., Skagen, K., et al. Increased subclinical atherosclerosis in patients with chronic plaque psoriasis. Atherosclerosis 237 (2014), 499–503.
31. 31 Mehta, N.N., Yu, Y., Pinnelas, R., et al. Attributable risk estimate of severe psoriasis on major cardiovascular events. Am J Med 124 (2011), 775.e1–775.e6.
32. 32 Mehta, N.N., Krishnamoorthy, P., Yu, Y., et al. The impact of psoriasis on 10-year Framingham risk. J Am Acad Dermatol 67 (2012), 796–798.
33. 33 Gisondi, P., Farina, S., Giordano, M.V., Girolomoni, G., Usefulness of the Framingham risk score in patients with chronic psoriasis. Am J Cardiol 106 (2010), 1754–1757.
34. 34 Peters, M.J., Symmons, D.P., McCarey, D., et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69 (2010), 325–331.